These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15357914)

  • 1. An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser.
    Watkins SM
    Assay Drug Dev Technol; 2004 Aug; 2(4):339-43. PubMed ID: 15357914
    [No Abstract]   [Full Text] [Related]  

  • 2. An interview with D. Lansing Taylor, Ph.D., Chief Executive Officer, Cellomics, Inc. Interview by Vicki Glaser.
    Taylor DL
    Assay Drug Dev Technol; 2003 Aug; 1(4):501-5. PubMed ID: 15090246
    [No Abstract]   [Full Text] [Related]  

  • 3. An interview with Ken Valenzano, Ph.D. Interview by Vicki Glaser.
    Valenzano KJ
    Assay Drug Dev Technol; 2011 Jun; 9(3):191-7. PubMed ID: 21612548
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with Kenneth C. Lewis, Ph.D., CEO, and Joseph D. Simpkins, Vice President, Software, OpAns (Optimized Analytical Solutions), Durham, NC. Interview by Vicki Glaser.
    Lewis KC; Simpkins JD
    Assay Drug Dev Technol; 2007 Dec; 5(6):695-702. PubMed ID: 18181688
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 6. An interview with Doriano Fabbro, Ph.D., Novartis Biomedical Research Institute. Interviewed by Vicki Glaser.
    Fabbro D
    Assay Drug Dev Technol; 2004 Apr; 2(2):109-14. PubMed ID: 15165506
    [No Abstract]   [Full Text] [Related]  

  • 7. Private company profiles.
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Delivery 2007--New technologies, partnering and strategies for the future.
    Stevenson L
    IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
    [No Abstract]   [Full Text] [Related]  

  • 9. An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser.
    England P
    Assay Drug Dev Technol; 2004 Apr; 2(2):115-20. PubMed ID: 15165507
    [No Abstract]   [Full Text] [Related]  

  • 10. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
    Rantanen J; Khinast J
    Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
    [No Abstract]   [Full Text] [Related]  

  • 11. Pfizer-Pharmacia: the smart fit for the future.
    Wiggins WP
    Expert Opin Investig Drugs; 2003 Jan; 12(1):1-3. PubMed ID: 12517249
    [No Abstract]   [Full Text] [Related]  

  • 12. Carlo Incerti.
    Incerti C
    Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428
    [No Abstract]   [Full Text] [Related]  

  • 13. An interview with Peter J. Coassin. Interview by Vicki Glaser.
    Coassin PJ
    Assay Drug Dev Technol; 2005 Apr; 3(2):125-31. PubMed ID: 15871687
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from 54 years of pharmaceutical research.
    Firestone RA
    Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986
    [No Abstract]   [Full Text] [Related]  

  • 15. An Interview with Matthew P. Greving, PhD. Interview by Vicki Glaser.
    Greving MP
    Assay Drug Dev Technol; 2011 Oct; 9(5):431-5. PubMed ID: 21955100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Badman C; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):779-80. PubMed ID: 25501284
    [No Abstract]   [Full Text] [Related]  

  • 17. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 18. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 19. RNAi gets vote of confidence from big pharma.
    Frederickson RM
    Mol Ther; 2007 Feb; 15(2):221-2. PubMed ID: 17235294
    [No Abstract]   [Full Text] [Related]  

  • 20. Interview with Marc Ferrer, Ph.D.. Interview by Vicki Glaser.
    Ferrer M
    Assay Drug Dev Technol; 2010 Jun; 8(3):263-7. PubMed ID: 20589994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.